{"id":6865,"date":"2022-03-07T15:00:00","date_gmt":"2022-03-07T15:00:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/3681664_CN81664_0"},"modified":"2022-03-07T15:00:00","modified_gmt":"2022-03-07T15:00:00","slug":"singleron-acquires-proteona","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=6865","title":{"rendered":"Singleron Acquires Proteona"},"content":{"rendered":"

NANJING<\/span>\/SUZHOU, China<\/span> and COLOGNE, Germany<\/span> and SINGAPORE<\/span>, March 7, 2022<\/span> \/PRNewswire\/ — Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platform technologies and promotes their clinical translations, today announced the acquisition of Proteona Pte. Ltd., a Singapore<\/span>-based precision medicine company offering single-cell biomarker discovery services to translational and clinical researchers across the globe. By acquiring Proteona’s existing network throughout greater Asia<\/span>, Europe<\/span>, the US and Canada<\/span>, the acquisition strengthens Singleron’s position outside China<\/span> and provides Singleron access to Proteona’s technologies for single-cell multi-omic analysis and expertise in generating insights for the Biopharmaceutical market.<\/p>\n

\n

\"Combination<\/a>
Combination of Singleron and Proteona logos<\/span><\/p>\n<\/p><\/div>\n

Founded in 2017 by Jonathan Scolnick<\/span>, Gene Yeo<\/span>, and Shawn Hoon<\/span>, Proteona specializes in combining single-cell proteogenomic analysis with machine learning methods to identify novel biomarkers and generate machine-learning based predictive models of disease severity and therapeutic response. To support these efforts Proteona has developed innovative methods for single-cell multi-omic analysis and data interpretation. These include tools such as MapCell\u2122 for cell annotation and MapBatch\u2122 for batch correction that have significant advantages over conventional single-cell based methods for data analysis. Proteona’s efforts in the translational research arena were recently highlighted in three presentations at the American Society for Hematology in December 2021<\/span>.<\/p>\n

“We are very excited about the opportunity to work with Proteona since both companies are focused on bringing breakthrough single cell technologies to the clinic,” said Dr. Nan Fang<\/span>, CEO and Co-founder of Singleron. “Proteona’s expertise in generating clinically-relevant insights together with pharma partners and clinicians has enormous synergy with Singleron’s vision to advance precision medicine by combining single-cell multi-omics technologies and data science”.<\/p>\n

“Singleron is a perfect home for Proteona,” said Proteona CEO, Dr. Andreas Schmidt<\/span><\/span>. “Singleron’s technology and resources will help us accelerate our shared vision for single-cell based precision medicine. We are particularly interested in exploring the unique advantages Singleron’s technology may offer for clinical research”.<\/p>\n

About Singleron<\/b><\/p>\n

Founded in 2018, Singleron develops and commercializes single-cell multi-omics products that can be used in both research and clinical settings. Its current product portfolio includes instruments, microfluidic devices, reagents, software analysis and database solutions that facilitate high-throughput single-cell analysis. The company currently has offices, laboratories, and manufacturing facilities in China<\/span>, Germany<\/span>, and the US. Its products are used in over 1,000 laboratories including hospitals, research institutes, and pharmaceutical companies.<\/p>\n

About Proteona<\/b><\/p>\n

Proteona is a biomedical company in Singapore<\/span>, Germany<\/span>, and the US that is pioneering the use of single-cell proteogenomics to improve clinical outcomes in cancer. Using a combination of innovative single-cell assays and AI-assisted bioinformatics. Proteona provides a comprehensive sample-to-answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles.<\/p>\n

Media Contact: Email: <\/span>pr@singleron.com<\/span><\/a><\/p>\n

\"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/singleron-acquires-proteona-301496782.html<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

NANJING\/SUZHOU, China and COLOGNE, Germany and SINGAPORE, March 7, 2022 \/PRNewswire\/ — Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platform technologies and promotes their clinical translations, today announced the acquisition of Proteona Pte. Ltd., a Singapore-based precision medicine company offering single-cell biomarker discovery services to translational and clinical researchers across […]<\/p>\n","protected":false},"author":8,"featured_media":6866,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-6865","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-news"],"yoast_head":"\nSingleron Acquires Proteona - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=6865\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Singleron Acquires Proteona - My Blog\" \/>\n<meta property=\"og:description\" content=\"NANJING\/SUZHOU, China and COLOGNE, Germany and SINGAPORE, March 7, 2022 \/PRNewswire\/ — Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platform technologies and promotes their clinical translations, today announced the acquisition of Proteona Pte. Ltd., a Singapore-based precision medicine company offering single-cell biomarker discovery services to translational and clinical researchers across […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=6865\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-07T15:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/03\/singleron-acquires-proteona.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"599\" \/>\n\t<meta property=\"og:image:height\" content=\"92\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=6865#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=6865\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"Singleron Acquires Proteona\",\"datePublished\":\"2022-03-07T15:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=6865\"},\"wordCount\":470,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=6865#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/singleron-acquires-proteona.jpg\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=6865\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=6865\",\"name\":\"Singleron Acquires Proteona - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=6865#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=6865#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/singleron-acquires-proteona.jpg\",\"datePublished\":\"2022-03-07T15:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=6865#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=6865\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=6865#primaryimage\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/singleron-acquires-proteona.jpg\",\"contentUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/03\\\/singleron-acquires-proteona.jpg\",\"width\":599,\"height\":92},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=6865#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Singleron Acquires Proteona\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Singleron Acquires Proteona - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=6865","og_locale":"en_US","og_type":"article","og_title":"Singleron Acquires Proteona - My Blog","og_description":"NANJING\/SUZHOU, China and COLOGNE, Germany and SINGAPORE, March 7, 2022 \/PRNewswire\/ — Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platform technologies and promotes their clinical translations, today announced the acquisition of Proteona Pte. Ltd., a Singapore-based precision medicine company offering single-cell biomarker discovery services to translational and clinical researchers across […]","og_url":"https:\/\/transmediavictoria.net.au\/?p=6865","og_site_name":"My Blog","article_published_time":"2022-03-07T15:00:00+00:00","og_image":[{"width":599,"height":92,"url":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/03\/singleron-acquires-proteona.jpg","type":"image\/jpeg"}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=6865#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=6865"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"Singleron Acquires Proteona","datePublished":"2022-03-07T15:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=6865"},"wordCount":470,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=6865#primaryimage"},"thumbnailUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/03\/singleron-acquires-proteona.jpg","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=6865","url":"https:\/\/transmediavictoria.net.au\/?p=6865","name":"Singleron Acquires Proteona - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=6865#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=6865#primaryimage"},"thumbnailUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/03\/singleron-acquires-proteona.jpg","datePublished":"2022-03-07T15:00:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=6865#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=6865"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=6865#primaryimage","url":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/03\/singleron-acquires-proteona.jpg","contentUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/03\/singleron-acquires-proteona.jpg","width":599,"height":92},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=6865#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"Singleron Acquires Proteona"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/6865","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6865"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/6865\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/media\/6866"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6865"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6865"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6865"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}